Li Deng-Ke
Keine laufenden Positionen mehr
Karriereverlauf von Li Deng-Ke
Ehemalige bekannte Positionen von Li Deng-Ke
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RICH PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 29.04.2011 | 29.03.2013 |
| Direktor/Vorstandsmitglied | 29.04.2011 | 29.03.2013 | |
| Finanzdirektor/CFO | 29.04.2011 | 29.03.2013 | |
| Präsident | 29.04.2011 | 29.03.2013 | |
| KTV Ltd. | Corporate Officer/Principal | - | - |
Ausbildung von Li Deng-Ke
| Sichuan Normal University | Undergraduate Degree |
Statistik
International
| China | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
| KTV Ltd. |
- Börse
- Insiders
- Li Deng-Ke
- Erfahrung
